What proportion of patients with chronic noncancer pain are prescribed an opioid medicine? Systematic review and meta-regression of observational studies.
chronic pain
opioid analgesic
systematic review
Journal
Journal of internal medicine
ISSN: 1365-2796
Titre abrégé: J Intern Med
Pays: England
ID NLM: 8904841
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
received:
11
09
2019
revised:
09
12
2019
accepted:
15
01
2020
pubmed:
27
2
2020
medline:
16
12
2020
entrez:
27
2
2020
Statut:
ppublish
Résumé
Guidelines now discourage opioid analgesics for chronic noncancer pain because the benefits frequently do not outweigh the harms. We aimed to determine the proportion of patients with chronic noncancer pain who are prescribed an opioid, the types prescribed and factors associated with prescribing. Database searches were conducted from inception to 29 October 2018 without language restrictions. We included observational studies of adults with chronic noncancer pain measuring opioid prescribing. Opioids were categorized as weak (e.g. codeine) or strong (e.g. oxycodone). Study quality was assessed using a risk of bias tool designed for observational studies measuring prevalence. Individual study results were pooled using a random-effects model. Meta-regression investigated study-level factors associated with prescribing (e.g. sampling year, geographic region as per World Health Organization). The overall evidence quality was assessed using Grading of Recommendations Assessment, Development and Evaluation criteria. Of the 42 studies (5,059,098 participants) identified, the majority (n = 28) were from the United States of America. Eleven studies were at low risk of bias. The pooled estimate of the proportion of patients with chronic noncancer pain prescribed opioids was 30.7% (95% CI 28.7% to 32.7%, n = 42 studies, moderate-quality evidence). Strong opioids were more frequently prescribed than weak (18.4% (95% CI 16.0-21.0%, n = 15 studies, low-quality evidence), versus 8.5% (95% CI 7.2-9.9%, n = 15 studies, low-quality evidence)). Meta-regression determined that opioid prescribing was associated with year of sampling (more prescribing in recent years) (P = 0.014) and not geographic region (P = 0.056). Opioid prescribing for patients with chronic noncancer pain is common and has increased over time.
Substances chimiques
Analgesics
0
Analgesics, Opioid
0
Types de publication
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
458-474Informations de copyright
© 2020 The Association for the Publication of the Journal of Internal Medicine.
Références
Berterame S, Erthal J, Thomas J et al. Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study. Lancet 2016; 387: 1644-56.
Kao MCJ, Minh LC, Huang GY, Mitra R, Smuck M. Trends in ambulatory physician opioid prescription in the United States, 1997-2009. PM R 2014; 6: 575-82.
Gomes T, Mamdani MM, Paterson MJ, Dhalla IA, Juurlink DN. Trends in high-dose opioid prescribing in Canada. Can Fam Phys 2014; 60: 826-32.
Bedson J, Chen Y, Ashworth J et al. Trends in long term opioid prescribing in primary care patients with musculoskeletal conditions: an observational database study. Pain 2016; 157: 1525-31.
Ruscitto A, Smith BH, Guthrie B. Changes in opioid and other analgesic use 1995-2010: repeated cross-sectional analysis of dispensed prescribing for a large geographical population in Scotland. Eur J Pain 2015; 19: 59-66.
Blanch B, Pearson S, Haber PS. An overview of the patterns of prescription opioids use, costs and related harms in Australia. Brit J Clin Pharmacol 2014; 78: 1159-66.
Braden JB, Fan MY, Edlund MJ, Martin BC, DeVries A, Sullivan MD. Trends in use of opioids by noncancer pain type 2000-2005 among Arkansas Medicaid and HealthCore enrollees: results from the TROUP study. J Pain 2008; 9: 1026-35.
Foy R, Leaman B, McCrorie C et al. Prescribed opioids in primary care: cross-sectional and longitudinal analyses of influence of patient and practice characteristics. BMJ Open 2016; 6: e010276.
Zin CS, Chen LC, Knaggs RD. Changes in trends and pattern of strong opioid prescribing in primary care. Eur J Pain 2014; 18: 1343-51.
Karanges EA, Blanch B, Buckley NA, Pearson SA. Twenty-five years of prescription opioid use in Australia: a whole-of-population analysis using pharmaceutical claims. Brit J Clin Pharmacol 2016; 82: 255-67.
Ospina M, Hartstall C. Prevalence of chronic pain: an overview. INAHTA Briefs. 2002. http://www.inahta.org/upload/Briefs_4/2004_19.pdf Accessed 18/11/19
Dahlhamer JLJ, Zelaya C, Nahin R et al. Prevalence of chronic pain and high-impact chronic pain among adults - United States, 2016. MMWR Morb Mortal Wkly Rep 2018; 67: 1001-06.
Fayaz A, Croft P, Langford RM, Donaldson LJ, Jones GT. Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies. BMJ Open 2016; 6: e010364.
Landmark T, Romundstad P, Dale O, Borchgrevink PC, Vatten L, Kaasa S. Chronic pain: one year prevalence and associated characteristics (the HUNT pain study). Scan J Pain 2013; 4: 182-87.
Institute of Medicine Committee on Advancing Pain Research CE. The National Academies Collection: Reports funded by National Institutes of Health. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington, DC: National Academies Press (US); 2011.
Wilkerson RG, Kim HK, Windsor TA, Mareiniss DP. The opioid epidemic in the United States. Emerg Med Clin N Am 2016; 34: e1-e23.
Dowell D, Haegerich HT, Chou R et al. CDC guideline for prescribing opioids for chronic pain - United States. MMWR Recomm Rep 2016; 65: 1-49.
National Institute for Health and Care Excellence. Low back pain and sciatica in over 16s: assessment and management. National Institute for Health and Care Excellence. 2016. www.nice.org.uk/guidance/ng59
Curtis HJ, Croker R, Walker AJ, Richards GC, Quinlan J, Goldacre B. Opioid prescribing trends and geographical variation in England, 1998-2018: a retrospective database study. Lancet Psychiatry 2019; 6: 140-50.
Chenaf C, Kabore JL, Delorme J et al. Prescription opioid analgesic use in France: Trends and impact on morbidity-mortality. Eur J Pain 2019; 23: 124-34.
Fischer B, Jones W, Vojtila L, Kurdyak P. Patterns, changes, and trends prescription opioid dispensing in Canada, 2005-2016. Pain Physician 2018; 21: 219-28.
Fredheim OM, Mahic M, Skurtveit S, Dale O, Romundstad P, Borchgrevink PC. Chronic pain and use of opioids: a population-based pharmacoepidemiological study from the Norwegian prescription database and the Nord-Trondelag health study. Pain 2014; 155: 1213-21.
Mazer-Amirshahi M, Mullins PM, Rasooly I, van den Anker J, Pines JM, Miner JR. Rising opioid prescribing in adult U.S. Emergency Department Visits: 2001-2010. Acad Emerg Med 2014; 21: 236-43.
Kaafarani HMA, Wakeman S, Ring D. The opioid epidemic and new legislation in Massachusetts: time for a culture change in surgery? Ann Surgery 2017; 265: 731-33.
Neuman MD, Bateman BT, Wunsch H. Inappropriate opioid prescription after surgery. Lancet 2019; 393: 1547-57.
Jeffery MM, Hooten WM, Hess EP et al. Opioid prescribing for opioid-naive patients in emergency departments and other settings: characteristics of prescriptions and association with long-term use. Ann Emerg Med 2017; 71: 326-36.
Levy B, Paulozzi L, Mack KA, Jones CM. Trends in opioid analgesic-prescribing rates by specialty US, 2007-2012. Am J Prev Med 2015; 49: 409-13.
Liberati A, Altman D, Tetzlaff J et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Medicine 2009; 6: e1000100.
Stroup DF, Berlin JA, Morton SC et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12.
WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment 2019. Oslo, Norway: WHO Collaborating Centre for Drug Statistics Methodology, 2018.
World Health Organisation. World health statistics. 2011. WHO Department of Health Statistics and Informatics of the Innovation. https://www.who.int/whosis/whostat/2011/en/. Accessed 15/7/19
World Bank. World bank country and lending groups. 2019. https://datahelpdesk.worldbank.org/knowledgebase/articles/906519. Accessed 31/10/19
Hoy D, Brooks P, Woolf A et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epi 2012; 65: 934-39.
Guyatt GH, Oxman AD, Vist GE, Falck-Ytter Y, Schunemann HJ. GRADE: What is "quality of evidence" and why is it important to clinicians? BMJ 2008; 336: 995-98.
Joint Formulary Committee. BNF 74. September 2017. London: Pharmaceutical Press.
Abdel Shaheed C, Maher CG, Williams KA, Day R, McLachlan AJ. Efficacy, tolerability, and dose-dependent effects of opioid analgesics for low back pain: a systematic review and meta-analysis. JAMA Intern Med 2016; 176: 958-68.
Beehler GP, Rodrigues AE, Mercurio-Riley D, Dunn AS. Primary care utilization among veterans with chronic musculoskeletal pain: a retrospective chart review. Pain Med 2013; 14: 1021-31.
Carbone LD, Chin AS, Lee TA et al. The association of opioid use with incident lower extremity fractures in spinal cord injury. J Spinal Cord Med 2013; 36: 91-96.
Clarke D. Chronic pain prevalence and analgesic prescribing in a general medical population. J Pain Sympt Man 2002; 23: 131-37.
Castillo RC, MacKenzie EJ, Wegener ST, Bosse MJ, Group LS. Prevalence of chronic pain seven years following limb threatening lower extremity trauma. Pain 2006; 124: 321-29.
Dobscha SK, Morasco BJ, Duckart JP, Macey T, Deyo RA. Correlates of prescription opioid initiation and long-term opioid use in veterans with persistent pain. Clin J Pain 2013; 29: 102-108.
Edlund MJ, Austen MA, Sullivan MD et al. Patterns of opioid use for chronic noncancer pain in the Veterans Health Administration from 2009 to 2011. Pain 2014; 155: 2337-43.
Gore M, Dukes E, Rowbotham DJ, Tai KS, Leslie D. Clinical characteristics and pain management among patients with painful peripheral neuropathic disorders in general practice settings. Euro J Pain 2007; 11: 652-64.
Mafi JN, McCarthy EP, Davis RB, Landon BE. Worsening Trends in the Management and Treatment of Back Pain. JAMA Intern Med 2013; 173: 1573-81.
Mafi JN, Edwards ST, Pedersen NP, Davis RB, McCarthy EP, Landon BE. Trends in the ambulatory management of headache: analysis of NAMCS and NHAMCS data 1999-2010. J Gen Intern Med 2015; 30: 548-55.
Mahowald ML, Singh JA, Majeski P. Opioid use by patients in an orthopedics spine clinic. Arthritis Rheum 2005; 52: 312-21.
Mapel DW, Shainline M, Paez K, Gunter M. Hospital, pharmacy, and outpatient costs for osteoarthritis and chronic back pain. J Rheumatol 2004; 31: 573-83.
Park PW, Dryer RD, Hegeman-Dingle R et al. Cost burden of chronic pain patients in a large integrated delivery system in the United States. Pain Pract 2016; 16: 1001-11.
Podichetty VK, Varley ES, Secic M. Role of patient-based health status outcome measurements in opioid management for low back pain. J Opioid Manag 2008; 4: 153-62.
Steinman MA, Komaiko KD, Fung KZ, Ritchie CS. Use of opioids and other analgesics by older adults in the United States, 1999-2010. Pain Med 2015; 16: 319-27.
Tian TY, Zlateva I, Anderson DR. Using electronic health records data to identify patients with chronic pain in a primary care setting. J Am Med Inform Assoc 2013; 20: e275-280.
Turk D, Okifuji A. What factors affect physicians' decisions to prescribe opioids for chronic noncancer pain patients? Clin J Pain 1997; 13: 330-36.
Young RA, Benold T, Whitham J, Burge S. Factors influencing work interference in patients with chronic low back pain: a Residency Research Network of Texas (RRNeT) study. J Am Board Fam Med 2011; 24: 503-510.
Dominick KL, Bosworth HB, Dudley TK, Waters SJ, Campbell LC, Keefe FJ. Patterns of opioid analgesic prescription among patients with osteoarthritis. J Pain Palliat Care Pharmacother 2009; 18: 31-46.
Richter MD, Achenbach S, Zamora-Legoff JA, Crowson CS. Matteson EL Opioid use in patients with polymyalgia rheumatica. Clin Exp Rheumatol 2017; 35: 1014-17.
Romanelli RJIL, Lynch B, Craig T, Cappelleri JC, Jukes T, Ishisaka DY. Opioid prescribing for chronic pain in a community-based healthcare system. Am J Manag Care 2017; 23: e138-e45.
Rolita L, Spegman A, Tang X, Cronstein BN. Greater number of narcotic analgesic prescriptions for osteoarthritis is associated with falls and fractures in elderly adults. J Am Geriatr Soc 2013; 61: 335-40.
Wright EA, Katz JN, Abrams S, Solomon DH, Losina E. Trends in prescription of opioids from 2003-2009 in persons with knee osteoarthritis. Arthritis Care Res 2014; 66: 1489-95.
Curtis JR, Xie F, Smith C et al. Changing trends in opioid use among patients with rheumatoid arthritis in the United States. Arthritis Rheumatol 2017; 69: 1733-40.
Zamora-Legoff JA, Achenbach SJ, Crowson CS, Krause ML, Davis JM 3rd, Matteson EL. Opioid use in patients with rheumatoid arthritis 2005-2014: a population-based comparative study. Clin Rheumatol 2016; 35: 1137-44.
Margolis JM, Masters ET, Cappelleri JC, Smith DM, Faulkner S. Evaluating increased resource use in fibromyalgia using electronic health records. Clinicoecon Outcomes Res 2016; 8: 675-83.
Mohanty AF, Helmer DA, Muthukutty A et al. Fibromyalgia syndrome care of Iraq- and Afghanistan-deployed veterans in veterans health administration. J Rehabil Res Dev 2016; 53: 45-58.
Robinson RL, Kroenke K, Mease P et al. Burden of illness and treatment patterns for patients with fibromyalgia. Pain Med 2012; 13: 1366-76.
Vincent A, Whipple MO, McAllister SJ, Aleman KM, St Sauver JL. A cross-sectional assessment of the prevalence of multiple chronic conditions and medication use in a sample of community-dwelling adults with fibromyalgia in Olmsted County, Minnesota. BMJ Open 2015; 5: e006681.
Almakadma YS, Simpson K. Opioid therapy in non-cancer chronic pain patients: trends and efficacy in different types of pain, patients age and gender. Saudi J Anaesth 2013; 7: 291-95.
Ashworth J, Green DJ, Dunn KM, Jordan KP. Opioid use among low back pain patients in primary care: is opioid prescription associated with disability at 6-month follow-up? Pain 2013; 154: 1038-44.
Berger A, Sadosky A, Dukes E, Edelsberg J, Oster G. Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study. BMC Neurol 2012; 12: 8.
Cowan DT, Wilson-Barnett J, Griffiths P, Allan LG. A survey of chronic noncancer pain patients prescribed opioid analgesics. Pain Med 2003; 4: 340-51.
Perez C, Margarit C, Serrano M. Spanish group of CHANGE PAIN study. Survey of European patients assessing their own noncancer chronic pain: results from Spain. Curr Med Res Opin 2013; 29: 643-51.
Wilson N, Sanchez-Riera L, Morros R et al. Drug utilization in patients with OA: a population-based study. Rheumatol 2015; 54: 860-67.
Videla SCE, Ribera MV, Montes A, Samper D, Fuentes J. Busquets C; Pain, Group UoHiC. Characteristics and outcomes of chronic pain patients referred to hospital pain clinics: a prospective observational study. Minerva Anestesiol 2017; 83: 12-22.
Birtwhistle R, Morkem R, Peat G et al. Prevalence and management of osteoarthritis in primary care: an epidemiologic cohort study from the Canadian Primary Care Sentinel Surveillance Network. CMAJ Open 2015; 3: E270-75.
Fitzcharles MA, Ste-Marie PA, Gamsa A, Ware MA, Shir Y. Opioid use, misuse, and abuse in patients labeled as fibromyalgia. Am J Med 2011; 124: 955-60.
Shadd JD, Ryan BL, Maddocks HL, McKay SD, Moulin DE. Neuropathic pain in a primary care electronic health record database. Eur J Pain 2015; 19: 715-21.
Jensen MK, Thomsen AB, Hojsted J. 10-year follow-up of chronic non-malignant pain patients: opioid use, health related quality of life and health care utilization. Eur J Pain 2006; 10: 423-33.
Henderson JV, Harrison CM, Britt HC, Bayram CF, Miller GC. Prevalence, causes, severity, impact, and management of chronic pain in Australian general practice patients. Pain Med 2013; 14: 1346-61.
Sule N. Burden of neuropathic pain in Indian patients attending urban, specialty clinics: results from a cross sectional study. Pain Pract 2008; 8: 362-78.
Goltz S, Cody A. Global access to pain relief: evidence for action. https://www.esmo.org/content/download/14123/252826/file/Global-Access-to-Pain-Relief-Evidence-for-Action.pdf. Accessed 18/11/19
Jarlbaek L. Opioid prescribing habits differ between Denmark, Sweden and Norway - and they change over time. Scand J Pain 2019; 19: 491-99.
Cohen D. Opioid prescriptions in England doubled over 12 years, study shows. BMJ 2017; 358: j4249.
Dowell D, Arias E, Kochanek K et al. Contribution of opioid-involved poisoning to the change in life expectancy in the United States, 2000-2015. JAMA 2017; 318: 1065-67.
Zhu W, Chernew ME, Sherry TB, Maestas N. Initial opioid prescriptions among U.S. commercially insured patients, 2012-2017. N Engl J Med 2019; 380: 1043-52.
International Narcotics Control Board. Availability on internationally controlled drugs: ensuring adequate access for medical and scientific purpose. 2016. http://www.incb.org/documents/Publications/AnnualReports/AR2015/English/Supplement-AR15_availability_English.pdf. Accessed 15/7/19
Vallath N, Rajagopal MR, Perera S, Khan F, Paudel BD, Tisocki K. Access to pain relief and essential opioids in the WHO South-East Asia Region: challenges in implementing drug reforms. WHO South-East Asia J Public Health 2018; 7: 67-72.
Institute for Health Metrics and Evaluation. Findings from the Global Burden of Disease Study 2017. Seattle, WA: IHME, 2018. http://www.healthdata.org/sites/default/files/files/policy_report/2019/GBD_2017_Booklet.pdf. Accessed 15/7/19.
Calcaterra SL, Yamashita TE, Min SJ, Keniston A, Frank JW, Binswanger IA. Opioid prescribing at hospital discharge contributes to chronic opioid use. J Gen Intern Med 2016; 31: 478-85.
Waljee JF, Li L, Brummett CM, Englesbe MJ. Iatrogenic opioid dependence in the United States: Are surgeons the gatekeepers? Ann Surg 2017; 265: 728-30.
Nataraj N, Zhang K, Guy GP Jr, Losby JL. Identifying opioid prescribing patterns for high-volume prescribers via cluster analysis. Drug Alcohol Depend 2019; 197: 250-54.
Zezza MA, Bachhuber MA. Payments from drug companies to physicians are associated with higher volume and more expensive opioid analgesic prescribing. PLoS ONE 2018; 13: e0209383.
Karanges EA, Buckley NA, Brett J et al. Trends in opioid utilisation in Australia, 2006-2015: Insights from multiple metrics. Pharmacoepidemiol Drug Saf 2018; 27: 504-12.
National Institute for Health. HEAL initiative. 2019. https://www.nih.gov/heal-initiative. Accessed 15/17/19.
Sandbank F. The time for opioid stewardship is now. Jt Comm J Qual Saf 2019; 45: 12.
Phelps P, Achey TS, Mieure KD et al. Survey of opioid medication stewardship practices at academic medical centers. Hosp Pharm 2019; 54: 57-62.
Therapeutic Goods Administration (TGA). Consultation: prescription strong (Schedule 8) opioid use and misuse in Australia - options for a regulatory response. 2018. https://www.tga.gov.au/sites/default/files/submissions-received-prescription-strong-schedule-8-opioid-use-and-misuse-in-australia-ppn.pdf. Accessed 15/17/19
Lombardi N, Vannacci A, Bettiol A et al. Prescribing trends of codeine-containing medications and other opioids in primary care after a regulatory decision: an interrupted time series analysis. Clin Drug Invest 2019; 39: 455-62.